151 related articles for article (PubMed ID: 19912164)
1. Physiologically based modelling and prediction of drug interactions.
Bois FY
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):154-61. PubMed ID: 19912164
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
Peters SA; Ungell AL; Dolgos H
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based pharmacokinetics (PBPK).
Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
[TBL] [Abstract][Full Text] [Related]
4. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
De Buck SS; Mackie CE
Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
[TBL] [Abstract][Full Text] [Related]
5. Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.
Willmann S; Thelen K; Lippert J
J Pharm Pharmacol; 2012 Jul; 64(7):997-1007. PubMed ID: 22686345
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?
Bouzom F; Ball K; Perdaems N; Walther B
Biopharm Drug Dispos; 2012 Mar; 33(2):55-71. PubMed ID: 22228149
[TBL] [Abstract][Full Text] [Related]
7. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
Lüpfert C; Reichel A
Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
[TBL] [Abstract][Full Text] [Related]
8. Use of clearance concepts and modeling techniques in the prediction of metabolic drug-drug interactions.
Ito K; Sugiyama Y
Trends Pharmacol Sci; 2010 Aug; 31(8):351-5. PubMed ID: 20542578
[TBL] [Abstract][Full Text] [Related]
9. Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions.
Baneyx G; Fukushima Y; Parrott N
Future Med Chem; 2012 Apr; 4(5):681-93. PubMed ID: 22458685
[TBL] [Abstract][Full Text] [Related]
10. PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals.
Bois FY; Jamei M; Clewell HJ
Toxicology; 2010 Dec; 278(3):256-67. PubMed ID: 20600548
[TBL] [Abstract][Full Text] [Related]
11. SysBioMed report: advancing systems biology for medical applications.
Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
[TBL] [Abstract][Full Text] [Related]
12. Application of PBPK modelling in drug discovery and development at Pfizer.
Jones HM; Dickins M; Youdim K; Gosset JR; Attkins NJ; Hay TL; Gurrell IK; Logan YR; Bungay PJ; Jones BC; Gardner IB
Xenobiotica; 2012 Jan; 42(1):94-106. PubMed ID: 22035569
[TBL] [Abstract][Full Text] [Related]
13. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.
Zhao P; Zhang L; Grillo JA; Liu Q; Bullock JM; Moon YJ; Song P; Brar SS; Madabushi R; Wu TC; Booth BP; Rahman NA; Reynolds KS; Gil Berglund E; Lesko LJ; Huang SM
Clin Pharmacol Ther; 2011 Feb; 89(2):259-67. PubMed ID: 21191381
[TBL] [Abstract][Full Text] [Related]
14. Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: a conceptual framework.
Dahl SG; Aarons L; Gundert-Remy U; Karlsson MO; Schneider YJ; Steimer JL; Trocóniz IF
Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):2-12. PubMed ID: 19686541
[TBL] [Abstract][Full Text] [Related]
15. The role of body-on-a-chip devices in drug and toxicity studies.
Esch MB; King TL; Shuler ML
Annu Rev Biomed Eng; 2011 Aug; 13():55-72. PubMed ID: 21513459
[TBL] [Abstract][Full Text] [Related]
16. Have physiologically-based pharmacokinetic models delivered?
Edginton AN; Joshi G
Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):929-34. PubMed ID: 21762039
[TBL] [Abstract][Full Text] [Related]
17. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.
Rostami-Hodjegan A
Clin Pharmacol Ther; 2012 Jul; 92(1):50-61. PubMed ID: 22644330
[TBL] [Abstract][Full Text] [Related]
19. Interplay of transporters and enzymes in drug and metabolite processing.
Pang KS; Maeng HJ; Fan J
Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
[TBL] [Abstract][Full Text] [Related]
20. Whole-body physiologically based pharmacokinetic models.
Nestorov I
Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):235-49. PubMed ID: 17428153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
